XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2021   355,400,000        
Beginning balance at Dec. 31, 2021 $ 5,706.2 $ 3.6 $ 2,717.6 $ 2,805.3 $ (247.5) $ 427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (1,700,000) (1,700,000)        
Shares repurchased $ (80.4)     (80.4)    
Equity-based compensation $ 39.0   39.0      
Shares issued for equity-based awards (in shares)   3,200,000        
Shares issued for performance allocations (in shares) 636,461 600,000        
Shares issued for performance allocations $ 31.3   31.3      
Shares issued related to the acquisition of CBAM (in shares)   4,200,000        
Shares issued related to the acquisition of CBAM 194.5   194.5      
Contributions 146.8         146.8
Dividends and distributions (236.6)     (89.5)   (147.1)
Net income 594.8     571.6   23.2
Currency translation adjustments (39.8)       (34.0) (5.8)
Defined benefit plans, net (1.5)       (1.5)  
Ending balance (in shares) at Mar. 31, 2022   361,700,000        
Ending balance at Mar. 31, 2022 $ 6,354.3 $ 3.6 2,982.4 3,207.0 (283.0) 444.3
Beginning balance (in shares) at Dec. 31, 2022 362,298,650 362,300,000        
Beginning balance at Dec. 31, 2022 $ 6,821.3 $ 3.6 3,138.5 3,401.1 (322.2) 600.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (3,000,000) (3,000,000.0)        
Shares repurchased $ (100.3)     (100.3)    
Equity-based compensation 54.8   54.8      
Shares issued for equity-based awards (in shares)   2,800,000        
Dividend-equivalent rights on certain equity-based awards $ 0.0   2.2 (2.2)    
Shares issued for performance allocations (in shares) 0          
Contributions $ 18.7         18.7
Dividends and distributions (128.3)     (118.4)   (9.9)
Net income 125.3     100.7   24.6
Currency translation adjustments 19.8       16.8 3.0
Defined benefit plans, net $ 0.2       0.2  
Ending balance (in shares) at Mar. 31, 2023 362,056,444 362,100,000        
Ending balance at Mar. 31, 2023 $ 6,811.5 $ 3.6 $ 3,195.5 $ 3,280.9 $ (305.2) $ 636.7